SCM
BIVV

Shelton Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Shelton Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,609
Closed -$464K – 911
2017
Q4 		$464K Hold
8,609
– – 0.03% 405
2017
Q3 		$491K Hold
8,609
– – 0.03% 366
2017
Q2 		$518K Buy
8,609
+1,494
+21% +$85.1K 0.04% 358
2017
Q1 		$387K Buy
+7,115
New +$350K 0.03% 458

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Shelton Capital Management's BIVV Position: Q1 2018 in Review

Shelton Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8,609 shares — an estimated $464K sold.

Shelton Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $518K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Shelton Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Shelton Capital Management sold 8,609 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $464K.
  • Shelton Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Shelton Capital Management's Bioverativ Inc. Common Stock position peaked at $518K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Shelton Capital Management's 13F filing for Q1 2018, filed 15 May 2018.